Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Frelinger

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Immunogenetics|January 1, 1981
Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia seraP J Wettstein, J G Frelinger, L Hood
Immunology Today|December 29, 1998
The Roman god Janus: a paradigm for the function of CD43J R Ostberg, R K Barth, J G Frelinger
Experimental and Clinical Immunogenetics|January 1, 1992
CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytesL Dragone, A Pallant, R Insel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growthB K Martin, J G Frelinger, J P Ting
Nature|November 1, 1979
Mouse epidermal Ia molecules have a bone marrow originJ G Frelinger, L Hood, S Hill, et al.
The Journal of Experimental Medicine|April 21, 1997
Anti-CD43 inhibition of T cell homingL M McEvoy, H Sun, J G Frelinger, et al.
Nucleic Acids Research|August 25, 1990
The nucleotide sequence of Ly 48 (mouse leukosialin, sialophorin): the mouse homolog of CD43K S Dorfman, W Litaker, C M Baecher, et al.
Immunology|August 14, 1999
Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cellsE Storozynsky, J G Woodward, J G Frelinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumorT M Blieden, A J McAdam, J G Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfectionD W Bahler, J G Frelinger, L W Harwell, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Immunogenetics|January 1, 1981
Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia seraP J Wettstein, J G Frelinger, L Hood
Immunology Today|December 29, 1998
The Roman god Janus: a paradigm for the function of CD43J R Ostberg, R K Barth, J G Frelinger
Experimental and Clinical Immunogenetics|January 1, 1992
CD43 is expressed normally on Wiskott-Aldrich-derived lymphocytesL Dragone, A Pallant, R Insel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growthB K Martin, J G Frelinger, J P Ting
Nature|November 1, 1979
Mouse epidermal Ia molecules have a bone marrow originJ G Frelinger, L Hood, S Hill, et al.
The Journal of Experimental Medicine|April 21, 1997
Anti-CD43 inhibition of T cell homingL M McEvoy, H Sun, J G Frelinger, et al.
Nucleic Acids Research|August 25, 1990
The nucleotide sequence of Ly 48 (mouse leukosialin, sialophorin): the mouse homolog of CD43K S Dorfman, W Litaker, C M Baecher, et al.
Immunology|August 14, 1999
Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cellsE Storozynsky, J G Woodward, J G Frelinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1991
Mechanism of cytolytic T lymphocyte killing of a low class I-expressing tumorT M Blieden, A J McAdam, J G Frelinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfectionD W Bahler, J G Frelinger, L W Harwell, et al.
Pageof 7